Recommended lawyer for Healthcare and life sciences
Stefanie is an expert in all regulatory, commercial and contractual matters in the pharmaceutical, medical device and biotech sector as well as in compliance-relevant topics in this area. She advises on the drafting and negotiation of complex and cross-border licensing agreements (out-licensing and in-licensing), research and development collaborations, manufacturing and distribution agreements as well as clinical trial agreements and with CROs.
In M&A and private equity transactions in the life sciences sector, she advises on all regulatory and contractual issues.
Recommended lawyer for Healthcare and life sciences
Law firm of the year for IP Law
Recommended lawyer: Healthcare and life sciences
Selecting your AIA notified body
Manufacturers/providers of medical devices that, according to the EU AI Act, include a high-risk AI system (HRAIS) require a notified body assessment of their technical documentation and/or quality management system should urgently consider which notified body to appoint.
by Dr. Stefanie Greifeneder and Alison Dennis
6 of 10 Insights
Word on the street at the J.P. Morgan Healthcare Conference 2025
by multiple authors
by Kathleen Munstermann-Senff, LL.M. (Medizinrecht) and Dr. Daniel Tietjen
by Colin McCall and Charlie Adams